Introduction
Extramedullary blast crisis of Philadelphia chromosome-positive (Ph(+)) chronic myelogenous leukemia (CML) is infrequent (4.0%, 1 sites are bone (37-57%), lymph node (17-29%), skin and soft tissue (14-29%), and central or peripheral nervous system (12-83%). Although cases with lymph node enlargement in patients with CML have been described following the first report by Frank et al 5 and reviewed, 6, 7 it is difficult to determine whether the blast cells are derived from the lymphoid or myelo-monocytoid lineages based only on morphology and cytochemistry. With the development of immunologic and molecular methods in the early 1980s, the cell of origin of extramedullary transformation of CML can generally be determined both in nodal and extranodal sites. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] The majority of nodal lymphoid tumors reported to occur in the setting of CML are of precursor thymic T cell origin, and are felt to represent evolution of CML to a lymphoid blast crisis involving a lymph node. In contrast, there are only two reports of lymphoid neoplasms of mature B cell phenotype recognized in the lymph nodes of CML patients. 13, 17 The neoplastic cells in a blast crisis of Ph(+) CML are believed to be derived from cells with genetic abnormalities similar to those of Ph(+) leukemia, 27 ,28 although, in rare cases, Ph chromosomes may be cytogenetically masked. 29 Similarly, if a lymphoid neoplasm in a lymph node is shown to be Ph(+) by conventional cytogenetics or molecular analysis (Southern blot analysis or reverse transcription polymerase chain reaction (RT-PCR)), it is generally regarded as a localized blast crisis, and also believed to have been generated from the genetic background of the CML. Hence, such patients typically receive chemotherapy for an extramedullary localized blast crisis in CML. 15, 16, 20, 21, 23, 25, 26 Interpretation of cytogenetic analysis, Southern blotting, or PCR, however, may be problematic because a certain percentage of reactive peripheral lymphocytes in CML chronic phase patients contain the BCR/ABL fusion gene by FISH 30 and because the positive results of BCR/ABL gene rearrangement by conventional cytogenetics or molecular analysis may be derived from admixed hematopoietic cells, not from the neoplastic cells. Until now, no evidence existed that the lymphoid neoplastic cells in CML patients with NHL contain BCR/ABL gene rearrangements.
Here we report two cases of Ph(−) peripheral NHLs identified in patients with chronic phase of Ph(+) CML. In both cases, BCR/ABL rearrangements were present in the tumor biopsy material by cytogenetic analysis, but the lymphoma cells did not contain rearrangements of BCR and ABL genes by FISH. We compare these cases with other reports of nodal lymphoid neoplasm occurring in the setting of CML, and with Ph(+) lymphomas that were identified in non-CML or nonacute lymphocytic leukemia patients.
Leukemia

Case reports
Case 1
A 59-year-old Japanese male (ST,S) was found incidentally to have a peripheral leukocytosis, and was evaluated at the Furukawa City Hospital in August 1992. Neither the liver nor spleen were enlarged. The initial examination of his peripheral blood showed a white cell count of 18 200/l with leukoerythroblastosis (11% band neutrophils, 56% segmented neutrophils, 3% basophils, 28% lymphocytes, 1% myeloblasts and 1% metamyelocytes). Examination of the bone marrow revealed myeloid hyperplasia. The activity of neutrophil alkaline phosphatase was low, and the hematological data were as follows: erythrocytes 512 × 10 4 /l, Hb 16.0 g/dl, Ht 47%, platelets 30.7 × 10 4 /l. Cytogenetic studies of bone marrow cells revealed the Ph chromosome in all cells analyzed (20 cells, standard type). The patient was diagnosed as having CML in chronic phase, and was treated with daily intramuscular administration of human lymphoblastoid interferon-␣ (6 million IU). Complete hematologic remission was obtained 2 months later.
In February 1993, an abrupt peripheral leukocytosis occurred, and hydroxyurea with interferon-␣ was used for therapy. After treatment, the patient's condition remained stable in the chronic phase of CML.
In March 1995, the patient was found to have cervical lymphadenopathy. Biochemical data showed mild elevation of the lactate dehydrogenase (LDH) level (501 U/l). Peripheral blood and bone marrow findings were typical for the chronic phase of CML and less than 2% of the nucleated marrow cells were blasts. At this stage, cytogenetic studies of bone marrow and peripheral blood cells showed t(9;22)(q34;q11), standard type. The histological diagnosis of a lymph node biopsy processed for multiparameter analysis, was NHL, histiocyte or T cell rich B cell variant of large cell lymphoma (Figure 1 ) with Table 1 Antibodies used in this study for immunohistochemistry and flow cytometry, and their reactivity with lymphoma cells
Antigens
Antibodies Source Reactivity of lymphoma cells Although the patient remained well after chemotherapy, lymphadenopathy around the abdominal aorta was found during a follow-up by CT scan in January 1996. Following this, the patient received chemotherapy with CHOP consisting of cyclophosphamide, doxorubicin, vincristine and predonisone, and obtained a complete remission. In July 1996, cervical lymph node enlargment was identified and a biopsy with multiparameter analysis was again performed. The histological features of NHL changed to diffuse large cell, immunoblastic variant with a marked decrease of other leukocyte components (Figure 2 ), and the pheno-/genotype was unchanged. After chemotherapy for relapsed NHL, his condition became gradually worse and he died on 21 November 1996. Autopsy revealed lymphoma involving cervical, pulmonary hilar, mediastinal, para-aortic, and retroperitoneal nodes, up to 3 cm in diameter. Bone marrow at autopsy showed hypercellularity consistent with chronic phase of CML without lymphoma cell infiltration.
Leukemia
Case 2
An 80-year-old Japanese male (FNYM, S) complained of general fatigue and visited the Sendai City Hospital in August 1995. Neither the liver nor spleen were enlarged. The initial examination of his peripheral blood showed a white cell count of 14 300/l with leukoerythroblastosis (2% promyelocyte, 15% myelocyte, 16% band neutrophils, 36% segmented neutrophils, 6% basophils, 3% eosinophils, 7% lymphocytes, 7% monocytes) with periodic fluctuations. Examination of the bone marrow revealed myeloid hyperplasia. The activity of neutrophil alkaline phosphatase was low, and the hematological data were as follows: erythrocytes 348 × 10 4 /l, Hb 9.6 g/dl, Ht 38.8%, platelets 28.8 × 10 4 /l. Cytogenetic studies of bone marrow cells revealed a Philadelphia chromosome in all cells analyzed (20 cells, standard type). The patient was diagnosed as having CML in chronic phase, and received no therapy because of his advanced age.
In June 1996, the patient complained of left chest pain and was admitted to the Sendai City Hospital for evaluation. He was found to have tumor masses and pleural effusion in the left thoracic cavity identified by both CT scan and chest Xray. Biochemical data showed marked elevation of LDH (2640 U/l). Peripheral blood and bone marrow findings were typical for chronic phase of CML and approximately 1% of the nucleated marrow cells were blasts. At this time, cytogenetic studies of bone marrow and peripheral blood cells showed a t(9;22)(q34;q11), standard type. Although a few large atypical cells were identified in the bloody pleural effusion as well as abundant other cell components such as mesothelial cells, histiocytes, neutrophils and lymphocytes, no definite cytological diagnosis besides malignant neoplasm was made prior to his death. He died of respiratory failure on 5 August 1996.
Autopsy revealed several soft nodules attached to the left parietal, parenchymal and diaphragmatic pleural surfaces, up to 3 cm in diameter, slightly invasive into adjacent tissue. The left lung was almost completely collapsed due to massive effusion (left: 2000 ml (bloody in color); right: 100 ml (serous in color). One of these nodules was examined with a multiparameter analysis. A histological diagnosis of NHL, CD30-positive anaplastic large cell variant ( Figure 3 ), with null cell pheno-/genotype was made. No tumor formation, apart from the left pleural cavity and its surrounding tissue, were identified. Bone marrow at autopsy showed hypercellularity consistent with CML, and there were no findings of blast crisis nor invasion of lymphoma cells.
Materials and methods
Morphological examination
One-half of the material in both cases was fixed in 20% nonbuffered formalin. Paraffin-embedded specimens were stained with routine hematoxylin and eosin (H&E) for histologic diagnosis. Small pieces of the tissue were fixed in 2% glutaraldehyde in a 0.1 M cacodylate buffer (pH 7.3) and processed for electron microscopic observation.
Three-color flow cytometry (3-FCM)
Antibodies used in 3-FCM, both monoclonal and polyclonal, are listed in Table 1 . The detailed procedures and combination of antibodies used for 3-FCM have been previously described. 31 
Immunohistochemistry
Thinly cut tissue fragments, approximately 5 × 5 × 1 mm in size, were fixed in PBS with 1% paraformaldehyde at 4°C on a shaker for 1.5 h, and washed in PBS with 20% sucrose at room temperature overnight, then quickly frozen in acetone at −70°C in a quick freezer (Shiraimatsu, Tokyo, Japan). Frozen sections were made and then stained with the unlabeled monoclonal antibodies listed in Table 1 , followed by an avidin-biotin peroxidase method for development. In addition to the antibodies used in 3-FCM, cytokeratin, vimentin, CD15, CD68 (KP-1 and PG-M1), CD117 (c-kit), TdT, neutrophil elastase and myeloperoxidase were stained by immunohistochemistry on frozen tissue. Immunohistochemical staining of paraffin sections was used to detect S100 protein and immunoglobulins.
Conventional cytogenetics
Cytogenetic studies were carried out according to a standard technique. 32 Tissue, lymph node, blood, or marrow cells were preserved at 4°C for 20 h for transportation. The cells were cultured overnight in RPMI 1640 with 15% fetal calf serum without mitogen (Biomedical Laboratories, Kawagoe, Japan). G-banded chromosomes were designated and described according to the Internal System for Human Cytogenetic Nomenclature (ISCN, 1995). 33 
Fluorescence in situ hybridization (FISH)
Double-labeling, two-color FISH was performed on the fixed cells obtained from the lymph node of the patients and preserved in Carnoy's fixative. 30, 34 The chromosome probes were labeled by nick translation using digoxigenin for BCR and biotin for ABL (BCR/ABL translocation DNA probes; ONCOR, Gaithersburg, MD, USA). After hybridization, the probes were detected by incubation with a mixture of rhodamine-labeled anti-digoxigenin and fluorescein-labeled avidin. Nuclei were identified by 4-6-diamidino-2-phenylindole (DAPI) stain. Fluorescent signals were visualized under a Nikon microscope with UV-2A and FITC/rhodamine dual band filters (Nikon, Japan).
Southern blotting
High molecular weight DNA was extracted from the tumor and bone marrow aspirates. Ten g of DNA was digested completely with the restriction enzymes BamHI, EcoRI, Hind III and BgIII, processed by the method of Southern, and hybridized to 32 P-labeled DNA probes. 35 Immunogenotyping was performed using probes for detection of C␤ (C␤1 and C␤2 genes of the human TCR ␤ chain, J␥ (J␥1 and J␥2) genes of the TCR ␥ chain, J␦1 gene of the TCR ␦ chain, J H gene of the immunoglobulin heavy () chain (IgH), C gene of the kappa chain and C gene of the lambda chain (Biomedical Laboratories). Rearrangement of BCR was tested using two kinds of BCR probe: the 0.6 kb BamHI-HindIII and the 1.2 kb EcoRI-HindIII genomic fragments.
36,37
Reverse transcription polymerase chain reaction (RT-PCR)
BCR/ABL gene rearrangement by RT-PCR was analyzed with two methods. The procedure for double amplification RT-PCR of a segment of the BCR/ABL fusion messenger RNA (mRNA) is described elsewhere. 38, 39 In brief, RNA was first extracted from each tumor and chronic phase CML bone marrow aspirLeukemia ate obtained at the time the tumor was identified in the patients, and then reverse-transcribed to make cDNA. The first round of PCR amplification was performed with the primers G and ␣ and the second round of PCR amplification was performed using nested primers F and A 38 in a Perkin-Elmer DNA thermal cycler 480 (Branchburg, NJ, USA). Both amplification rounds had 30 cycles, consisting of heat denaturation at 94°C, 1 min of annealing at 55°C, and 1 min of extension at 72°C (with the addition of 5 s each cycle), and a final extension period of 10 min. In the other method, a primer pair for a junction of mRNA between BCR exon 2 (with or without exon 3) and ABL exon 2 (sense: 5Ј-AGCATTCCGCTGACCATCAA-3Ј, antisense: 5Ј-CACTGGCCACAAAATCATAC-3Ј) provided 250 (with BCR exon 3) or 175 (without BCR exon 3) bp products (Biomedical Laboratories). A primer set for ␤-globin was also used for internal positive control. Amplification rounds had 45 cycles consisting of 1 min heat denaturation at 95°C, 1 min of annealing at 60°C, and 1.5 min of extension at 72°C. The size of BCR/ABL-derived products were analyzed in an agarose gel containing ethidium bromide.
Results
Morphology and immunophenotyping of the lymphomas
Histological examination of the initial lymph node biopsy in case 1 revealed abundant lymphocytes and histiocytes sur- The size of amplified BCR-ABL-derived products of both lymph node and bone marrow aspirates were same.
rounding large lymphoma cells (Figure 1a ). The lymphoma cells had large non-cleaved or polymorphous nuclei, often with prominent nucleoli and relatively abundant cytoplasm (Figure 1b) . These findings were more completely defined by electron microscopic examination (Figure 1e, f) . Morphologically, the case was classified as diffuse, large cell lymphoma of T cell and histiocyte rich B cell variant. Ultrastructurally, the cytoplasm contained infrequent mitochondria and moderately well developed rough endoplasmic reticulum. The cell surface was smooth without interdigitations or tight junctions. There were no granule-like structures suggesting myeloid differentiation. Lymphoma cell morphology of relapsed lymphoma was markedly changed and transformed to immunoblastic variant (Figure 2 ). The admixed reactive lymphocyte and histiocyte components among lymphoma cells were extremely depleted as compared with the initial one. Morphologic diagnosis of case 2 was CD30-positive anaplastic large cell lymphoma admixed with abundant leukocytes: neutrophils, lymphocytes and histiocytes ( Figure 3) . The large lymphoma cells had large polymorphous nuclei, often with prominent nucleoli and abundant cytoplasm. Ultrastructurally, no tight junctions or desmosome-like structures were identified between the lymphoma cells, and there found no granule-like structures suggesting myeloid differentiation (figure not shown).
Using 3-FCM and immunohistochemistry, it was possible to ascertain that there were no cells with immature thymocyte antigens (data not shown). The results of the phenotypic examination of lymphoma cells by enzyme immunohistochemistry are shown in Table 1 and Figure 1c + , IgG and lambda chain. TdT, CD117(c-kit), T cell markers, myeloid antigens, CD15, CD30, CD68, EMA and S100 were negative on lymphoma cells. The lymphoma cells in case 2 were positive for CD30 (Figure 3b ) and epithelial membrane antigen (EMA), yet negative for all other cell differentiation antigens. Ultrastructurally, no tight junction or desmosome-like structures were identified between the lymphoma cells in case 2 as well (figure not shown).
Conventional cytogenetics
Results of cytogenetic and molecular analysis are summarized in Table 2 .
All analyzed metaphases (10 cells in case 1 and 20 cells in case 2) obtained from the peripheral blood at the onset of CML showed 46, XY, t(9;22)(q34;q11), standard type. Cytogenetic analysis of the bone marrow isolated from both cases at the same time the lymph node enlargement (case 1) or thoracic tumor mass (case 2) was identified, revealed the same t(9;22)(q34;q11) translocation in 16 of 20 metaphases and 20 of 20 metaphases, respectively. Remaining cells in case 1 showed a normal karyotype. Only one karyotypic picture of peripheral blood in case 1, examined at relapse of lymphoma, is shown in Figure 4 . The results in peripheral or bone marrow cytogenetics in other specimens mentioned above revealed similar results.
No metaphases for cytogenetic analysis could be obtained from the initial lymph node biopsy of case 1 and case 2. Cytogenetic analysis of the lymph node at relapse in case 1, in which metaphases were obtained, showed karyotypic abnor-
Figure 5
A G-banded karyotype of lymphoma cells case 1 (relapsed). Cytogenetics showed complex abnormalities without t(9;22)(q34;q11) as follows: 81, XXYY, −1, i(1)(q10), del(1)(p32), del(1)(q23), −2, add(2)(q10), add(3)(p11), +der(3)add(3)(p11) t(3;18)(q27;q21), t(3;18)(q27;q21)x3, −4, der(4)t(4;22)(p16;q11) del(4)(q31), der(4)t(4;22)(p16;q11)add(4)(q35), −5, −6, der(6)t(6;14)(q15;q11), del(6)(p21)x2, −7, −7, −8, add(8)(p23), −9, −10, der(11)t(?6:11)(p11;q12)x2, del(12)(p13)x2, add(13)(q34), der(14)t(X;14)(q13;q32), −15, add(17)(p11), add (19) malities without t(9;22)(q34;q22) as follows ( Figure 5 ): 66-82, XXYY, −1, i(1)(q10), del(1)(p32), del(1)(q23), −2, add(2)(q10), add(3)(p11), +der(3)add(3)(p11)t(3;18)(q27;q21), t(3;18) (q27;q21)x3, −4, der(4)t(4;22)(p16;q11)del(4)(q31), der(4) t(4;22)(p16;q11)add(4)(q35), −5, −6, der(6)t(6;14)(q15;q11), del(6)(p21)x2, −7, −7, −8, add(8)(p23), −9,− 10,der(11)t(?6;11) (p11;q12)x2del(12)(p13)x2,add(13)(q34),der(14)t(X:14)(q13; q32), −15, add(17)(p11),add(19)(q13),der(19)t(1;19)(p13;q13), add(20)(q23), −21,der(22)t(4;22)(p16;q11), +mar [16] . Leukemia 
FISH
In the specimen of relapsed lymphoma in case 1, all metaphase lymphoma cells, which were large in size and showed hyperdiploidy, revealed an equal number of paired signals for BCR and ABL, respectively, and no BCR/ABL fusion signals were identified in any hyperdiploid cell (Figure 6b) . No fusion signals of the BCR/ABL gene were identified in the large and hyperdiploid lymphoma cells in case 2 (Table 2 ). In contrast, the Ph translocation could be identified by detection of BCL/ABL fusion signals in diploid interphase cells, which were smaller in size and considered to be reactive lymphocytes, in both initial lymph node biopsies of case 1 (Figure 6a ) and the tumor mass of case 2 (date not shown), as well as in the relapsed node from case 1. The percentages of interphase cells containing a BCR/ABL fusion signal were less than 20% of small lymphocytes in both cases.
Molecular (Southern blot and RT-PCR) analysis
By Southern blot analysis of DNA derived from the initially biopsied lymph node in case 1 (Figure 7) , a single rearranged band in IgH probe was seen in each enzyme digestion, while DNA derived from bone marrow aspirates of case 1 at the same time contained no rearranged bands of an IgH by Southern blot analysis ( Table 2) . Lymphoma tissue at relapse in case 1 showed rearranged fragments using an IgH probe of the same size as those seen in initial material (Table 2 ). Using the 0.6 kb BCR probe, a single rearranged band in BamHI and HindIll digestions and three rearranged bands in BglII were identified in the initial lymph node biopsy of case 1 ( Figure  7 ), and only a single rearranged band was identified in BglII digested material using the 1.2 kb BCR probe. The size of rearranged fragments between BamHI and HindIII digestion of IgH and BCR probes in lymph node was different, while the size and number of the rearranged fragments in BCR gene analysis were the same in the lymph node and bone marrow aspirates (Table 2) .
No rearranged bands were identified with any probe for T cell or B cell lineages by Southern blot analysis of the DNA derived from the tumor and bone marrow sampled during case 2's autopsy (Table 2 ). In contrast, rearranged bands were identified using both 0.6 kb and 1.2 kb BCR probes (Table 2) .
In both the initial lymph node and the lymph node at the time of relapse in case 1 contained BCR/ABL-positive cells detectable by RT-PCR (Figure 8) , and the size of amplified BCR/ABL-derived PCR products of both lesions were the same. Although no rearranged fragments were identified in the relapsed lymphoma in case 1 by Southern blot analysis with any BCR probe, an amplified band of BCR/ABL fusion was obtained. Amplified BCR/ABL-derived PCR products were detected in the lymphoma and bone marrow of case 2 ( Figure 8 ).
Discussion and review of the literature
The phenotype and cell morphology of blast cells in B-lymphoid crisis in CML are indistinguishable from those of ALL. 40 Histologically, the cells of typical B cell lymphoid crisis of CML in bone marrow or extramedullary (including nodal) sites have an immature cell morphology similar to lymphoblastic lymphoma. 41 However, our cases are considered to be peripheral lymphomas based on the immunohistochemical findings of negativity for immature lymphoid antigens, such as TdT, CD117(c-kit) and CD10, as well as the morphologic appearance of the lymphoma cells.
The two cases presented here were not associated with the Ph chromosome in lymphoma cells, a critical genetic determinant of CML. FISH analysis showed the presence of paired BCR and ABL genes without any fusion signal between them in large hyperdiploid lymphoma cells. In addition, the lymph nodes did not contain cells with either immature myeloid or precursor T (thymocyte) antigen expression as defined by both 3-FCM and immunohistochemistry. Furthermore, there was no evidence of a fusion between the BCR and immunoglobulin heavy chain gene in our cases because of the different-sized rearranged fragments in the lanes of the same restriction enzyme digestions between them. Hence, we emphasize that extramedullary lymphoid neoplasms in our cases could not be interpreted as blast crises of Ph(+) CML, but should be diagnosed as true Ph(−) NHLs.
Rearranged fragments of the BCR gene which were identified by Southern blot analysis of the initial biopsy of case 1 and tumor of case 2 were considered to be derived from admixed lymphocytes, neutrophils or histiocytes that contained the t(9;22)(q34;q11). The size of the rearranged fragments were identical to those of bone marrow CML cells, and therefore likely represented 'contaminating' Ph(+) CML cells. This idea can be supported by the findings that no rearranged fragments with BCR gene probe could be identified in the second relapse biopsy in case 1, in which infiltration of the tumor tissue with non-lymphoma cells was minimal. Therefore we conclude that it would be incorrect to interpret lymphoid neoplasms arising in Ph(+) CML patients as necessarily secondary to either CML or a lymphoid blast crisis with lymphoma tissue is analyzed for BCR/ABL only by Southern blot or RT-PCR, especially in tumors that contains abundant lymphocytes or neutrophils. Moreover, use of even more sensitive PCR tests for the BCR/ABL fusion gene must be carefully evaluated since false positives may be generated detected even from normal peripheral lymphocytes at a low level 42 as is also true for the BCL-2 oncogene. 43 Conversely, some cases of NHL are likely to be truly associated with the Ph chromosome, since Ph(+) lymphocytes, predominantly in B cells, may exist in peripheral blood or lymph nodes in a CML patient. 30 In our cases, a single BCR/ABL fusion signal was identified in small-sized and diploid reactive lymphocytes in the lesion. Although a clear definition of blast crisis in CML is not always easy, such a lymphoma must be called 'true' extramedullary localized blast crisis.
A review of the literature revealed 20 cases reported in which patients had both CML and lymph node enlargement, and in which immunophenotypic analyses are available for Table 3 Review of the cases with immunophenotypic examinations that had both CML and lymphoid neoplasia in the lymph node review (Table 3) . Sixteen of the 20 cases were considered to be consistent with an immature thymocyte phenotype because of positive findings for TdT, CD1a, CD7 or CD2 with surface CD3 negativity, and/or consistent cell morphology. These results parallel those of T-blast cells in the peripheral blood or bone marrow in the blastic phase of CML. 44 This is especially true in the case of Hirose et al, 15 in which the phenotype was quite similar to the 'precursor T cell phenotype' stage between T/NK cell common progenitor (TdT
+ ) and T cell precursor with TCR gene rearrangement, which was proposed by Lanier et al 45 and Sanches et al. 46 The cell morphology of that case was described as 'medium-sized, cleaved cell' and might represent a 'convoluted lymphoblastic' cell type. Unfortunately, no microscopic figures were shown and further evaluation to clarify this point is not possible. Only two cases were peripheral T cell lymphomas, and one of them was a CD30-positive anaplastic large cell lymphoma.
In contrast, there are only two cases in the literature of CML showing lymph node involvement by cells having a B cell phenotype (Table 3) . Unfortunately, neither an expression of CD10 and TdT, nor association of BCR/ABL, in the B cell lymphoma arising in these CML patients was described in any of the cases. The small number of CML associated B cell lymphomas, however, may not reflect the true incidence, since lymph node involvement in CML, in many instances, may have been assumed to represent evolution to precursor B cell blast crisis, and not malignant lymphoma of a mature B cell phenotype. By conventional cytogenetics Southern blot or RT-PCR analysis only, it was concluded that the tumors might be secondary to the event of Ph(+) CML history of the patients. From the examination of our cases, however, without FISH, it would be hard to determine whether the lymphoid neoplasms in the literature truly carried the BCR/ABL gene translocation in their lymphomagenesis.
On the other hand, there are 12 reported cases of so-called 'Ph(+) lymphomas' occurring in patients without a diagnosis of CML or ALL ( Table 4 ). The majority of these cases (8/12) have been of B cell origin. [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] All Ph(+) B cell lymphomas histologically showed a peripheral B cell type, that is, no 'blastic' features, three of which also showed negativity for CD10. [53] [54] [55] Most cases may be much more likely genetically Ph(+) lymphomas since their BCR/ABL rearrangements were demonstrated by conventional cytogenetics and BCL/ABL protein analysis, besides Southern blot analysis. However, it must be confirmed from the examination of our cases that it would be quite difficult to state whether the NHL truly carried the BCR/ABL gene translocation without FISH.
Therefore, there are now three types of lymphoid neoplasms related to Ph chromosome or status of CML as follows.
Type A:
Lymphoid blast crisis (both localized or not localized) consisting of Ph(+) cells in Ph(+) CML (same genetic background for both lymphoid neoplasm and CML). Type B:
Ph(−) lymphoid neoplasm occurring in Ph(+) CML (different genetic background between lymphoid neoplasm and CML). Type C:
Ph(+) lymphoid neoplasm in a patient without Ph(+) disorders.
Type B cases have often not been recognized in the past because nodal tumors which occur in the setting of CML have been assumed to be of primitive myeloid or precursor lymphoid origin without biopsy. However, it is quite important to distinguish the former two types: a neoplastic lesion, type A and B, in a CML patient to evaluate and treat the patients with appropriate chemotherapy; the former for blast crisis of CML and the latter for NHL of usual type, respectively. Moreover, patients of the two categories should be followed up and observed as independent groups for their clinical outcome.
Further study of these types of lymphoid neoplasms, as well as type C, is necessary to clarify the pathogenetic relationship between CML and NHL.
